Furthermore, another direct target of miR-34 is BCL2, which has been correlated with lower survival (Campana et al., 1993) and high risk features (Kaparou et al., 2013) in acute lymphoblastic leukemia. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.